Halothane induced fulminant hepatic failure

Journal of the College of Physicians and Surgeons Pakistan

Volumn 17, Issue 2, 2007, Pages 103-104

  Qureshi, Muhammad Azhar ^a   Saeed, Farrukh ^b   Hussain, Tassawar ^c  

^a PAF Hospital   (Pakistan)

^b CMH   (Pakistan)

^c AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

Halothane hepatitis; Halothane hypersensitivity; Inhalational anaesthetics

Indexed keywords

HALOTHANE; INHALATION ANESTHETIC AGENT;

ADULT; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; FATALITY; HUMAN; LIVER FAILURE; MALE; TOXIC HEPATITIS;

ADULT; ANESTHETICS, INHALATION; FATAL OUTCOME; HALOTHANE; HEPATITIS, TOXIC; HUMANS; LIVER FAILURE, ACUTE; MALE;

EID: 35248844599     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Mushambi MC, Smith G. Inhalation anaesthetic agents. In: Aitkenhead AR, Rowbotham DJ, Smith G, (edi). Textbook of anaesthesia. 4th ed. Edinburgh: Churchill Livingstone, 2001; 153-168
2. 2. Kumar GP, Bhat VJ, Sowdi V. Fulminant hepatic failure following halothane anaesthesia. J Clin Forensic Med 2005; 12: 271-273 (Pubitemid 41448026)
3. Mikhail MS, Murray MJ. Inhalation anaesthetics. In: Morgan GE, Mikhail MS, Murray MJ, (edi). Clinical anaesthesiology. 4th ed. New York: McGraw-Hill; 2006; 168.
4. Zimmerman HJ. Drug-induced liver disease. In: Schiff ER, Sorrell MF, Maddrey WC, (edi). Schiffs diseases of the liver. 8th ed. Philadelphia: Lippincott- Williams & Wilkins; 1999; 973.
5. Gut J. Molecular basis of halothane hepatitis. Arch Toxicol Suppl 1998; 20: 3-17.
6. Spracklin DK, Hankins DC, Fisher JM, Thummel KE, Kharasch ED. Cytochrome P450 2E1 is the principal catalyst of human oxidative halothane metabolism in vitro. J Pharmacol Exp Ther 1997; 281: 400-411
7. 7. Bourdi M, Amouzadeh HR, Rushmore TH, Martin JL. Halothaneinduced liver injury in out bred guinea pigs: role of trifluoroacetylated protein adducts in animal susceptibility. Chem Res Toxicol 2001; 14: 362-370 (Pubitemid 32367469)
8. Huwyler J, Aeschlimann D, Christen U, Gut J. The kidney as a novel target tissue for protein adduct formation associated with metabolism of halothane and the candidate chlorofluorocarbon replacement 2,2-dichloro-1, 1,1-trifluoroethane. Eur J Biochem 1992; 207: 229-238
9. Beaune P, Pessayre D, Dansette P, Mansuy D, Manns M. Autoantibodies against cytochromes P450: role in human diseases. Adv Pharmacol 1994; 30: 199-245.
10. 10. Bjornsson E, Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology 2005 42: 481-489 (Pubitemid 41061102)